Reaction

Product Dosage Form Issue reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 476 reports · 3 co-occurring drugs

As of the last recalculation, Product Dosage Form Issue appears in 476 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (PRR 87.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Buprenorphine Hydrochloride, Naloxone Hydrochloride4487.887.9
Mometasone Furoate And Formoterol Fumarate Dihydrate822.822.8
Rimegepant Sulfate621.021.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.